Skip to content

Blood Pressure Monitoring in Postpartum Women at Risk of Hypertension

Blood Pressure Monitoring in Postpartum Women at Risk of Hypertension

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05457504
Enrollment
200
Registered
2022-07-14
Start date
2022-07-31
Completion date
2023-12-31
Last updated
2022-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hypertension With Pre-Eclampsia, Gestational Hypertension, Hypertension Complicating Pregnancy, Childbirth, and the Puerperium, Hypertension in Pregnancy, Preeclampsia

Brief summary

Cardiovascular disease and hypertensive disorders of pregnancy (HDP) are the leading causes of maternal morbidity and mortality in the United States. Postpartum, in office care has demonstrated to be an insufficient model of hypertensive management postpartum, largely due to barriers that women face in accessing in office care, with stark racial disparities in access. The care of postpartum patients with HDP following delivery is made up of either a single postpartum visit at 6 weeks postpartum or a fragmented and non-standardized series of in-person appointments depending on the patients' medical complications and the clinicians' experience. Further, current society guidelines outline inpatient thresholds for initiation of antihypertensive medication but do not provide recommendations for titration thereafter. The proposed study will investigate the acceptability and effectiveness of an algorithm-based, outpatient treatment model for the management of postpartum hypertension utilizing an asynchronous text-based platform as compared to the standard of care for postpartum women with a diagnosis of Hypertensive disorder of pregnancy at Massachusetts General Hospital.

Interventions

Participants assigned to this arm will participate in the experimental intervention

BEHAVIORALUsual Care

Participants assigned to this arm will participate in a placebo intervention

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Intervention model description

In this study, we are testing different strategies to help women decrease issues with hypertension in the postpartum period. Participants may or may not undergo some of the following study procedures: * Frequent blood pressure monitoring and feedback * Receive information related to blood pressure measurement, heart disease prevention, etc. * Regular blood pressure monitoring and advice regarding changes in medications.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 years * Diagnosis of gestational hypertension (Systolic Blood Pressure (SBP)≥140 or Diastolic Blood Pressure (DBP) ≥90 on at least two occasions at least 4 hours apart after 20 weeks gestation in previously normotensive women) and or preeclampsia (SBP≥140 or DBP ≥90, proteinuria with or without symptoms of preeclampsia (headache, vision changes, right upper quadrant pain), and presentation of symptoms/lab abnormalities but no proteinuria) * English and Spanish-speaking * Delivering at Massachusetts General Hospital

Exclusion criteria

* Chronic hypertension or underlying cardiovascular disease

Design outcomes

Primary

MeasureTime frameDescription
Percent of patients who are normotensive at 6 weeks postpartum by American College of Cardiology (ACC)/American Heart Association (AHA) guidelines6 weeksPercent of patients who are normotensive at 6 weeks postpartum by ACC/AHA guidelines (\>130/80) in each treatment group

Secondary

MeasureTime frameDescription
Percent of patients who are normotensive at 6 weeks postpartum by American College of Obstetricians and Gynecologists (ACOG) guidelines6 weeksPercent of patients who are normotensive at 6 weeks postpartum by ACOG guidelines (\>140/90) in each treatment group
Frequency of Hospital readmission6 weeksFrequency of Hospital readmission in the first 6 weeks postpartum in each treatment group
Number of medication titrations6 weeksMean number of medication titrations by patient in the first 6 postpartum weeks in each treatment group
Adherence with scheduled outpatient clinical appointments6 monthsPercent of scheduled outpatient clinical appointments attended by patients in the first 6 postpartum months in each treatment group
Establishment of care with a primary care doctor1 yearPercent of patients who attend a primary care doctor visit in the first postpartum year in each treatment group

Contacts

Primary ContactIlona T Goldfarb, MD
igoldfarb@partners.org617-724-2640

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026